DexCom, Inc.
Marktkapitalisierung
$33.5B
Globaler Rang
#297
Allzeithoch
$51.8B
2021-12-31
Gesamtwachstum
+0%
seit 2026
Market Cap Context
- Larger than 19% of the 367 companies we track (globally).
- Equivalent to 0.1% of United States's GDP (2025 data).
- Just above: #296 Coinbase Global, Inc. ($33.5B)
- Just below: #298 DENSO Corporation ($32.3B)
- Best year: 2009 (+192%). Worst year: 2008 (-69%).
DexCom, Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance — DXCM annual filings (2025) →$4.7B revenue · $0.9B operating income · $0.8B net income
- ●Operating margin: 19.6% on $4.7B in revenue.
- ●R&D is 12.9% of revenue ($0.6B).
- ●Net income margin: 17.9% — $0.8B in profit.
- ●Free cash flow: $1.1B (23.1% of revenue).
Cost / Operating Expenses
Total operating expenses $3.8B
Total
$3.8B
Capital Expenditures
$0.4B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$1.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Über DexCom, Inc.
DexCom, Inc. (DXCM) is a United States-based company in the Medical Devices industry, part of the Healthcare sector. With a current market capitalization of $33.5B, it is ranked #297 among the world's largest companies. Its market cap peaked at $51.8B and reached as high as rank #199 in 2021.
Verlauf der Marktkapitalisierung von DexCom, Inc. (2026–2026)
DexCom, Inc. vs Sector Peers by Market Cap
DexCom, Inc. vergleichen
Rangverlauf
| Jahr | Marktkapitalisierung | Rang | Veränderung ggü. Vorjahr |
|---|---|---|---|
| 2026 | $33.5B | #297(↑22) | +30.8% |
| 2025 | $25.6B | #319(↓21) | -14.7% |
| 2024 | $30.0B | #298(↓70) | -37.3% |
| 2023 | $47.9B | #228(↓26) | +9.6% |
| 2022 | $43.7B | #202(↓3) | -15.6% |
| 2021 | $51.8B | #199(↑31) | +45.2% |
| 2020 | $35.7B | #230(↑40) | +69.0% |
| 2019 | $21.1B | #270(↑21) | +82.6% |
| 2018 | $11.6B | #291(↑15) | +108.7% |
| 2017 | $5.5B | #306(↓11) | -3.9% |
| 2016 | $5.8B | #295(↓24) | -27.1% |
| 2015 | $7.9B | #271(↑11) | +48.8% |
| 2014 | $5.3B | #282(↑7) | +55.5% |
| 2013 | $3.4B | #289(↑2) | +160.6% |
| 2012 | $1.3B | #291(↓2) | +46.0% |
| 2011 | $898.1M | #289(↓6) | -31.8% |
| 2010 | $1.3B | #283(↓3) | +69.1% |
| 2009 | $778.5M | #280(↑2) | +192.4% |
| 2008 | $266.3M | #282(↓8) | -68.7% |
| 2007 | $851.8M | #274(↓8) | -10.4% |
| 2006 | $951.2M | #266(↓8) | -33.9% |
| 2005 | $1.4B | #258 |
Weitere Unternehmen im Sektor Gesundheitswesen
FAQ
What is DexCom, Inc.'s market cap?
DexCom, Inc. (DXCM) has a market capitalization of $33.5B, making it the #297 largest company in the world by market cap.
What was DexCom, Inc.'s highest market cap?
DexCom, Inc.'s all-time high market cap was $51.8B, reached in 2021-12-31. Its highest rank was #199 in 2021.
What sector is DexCom, Inc. in?
DexCom, Inc. is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has DexCom, Inc.'s market cap changed over time?
DexCom, Inc. has been tracked since 2026. Its market cap has grown by 0% from $33.5B in 2026 to $33.5B today.